What is the recommended acute treatment for an adult migraine attack?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Acute Migraine

Start with NSAIDs (ibuprofen, naproxen, or aspirin) or acetaminophen at adequate doses; if insufficient relief after appropriate dosing, add a triptan to the NSAID (or to acetaminophen if NSAIDs are contraindicated). 1

First-Line Approach: NSAIDs and Acetaminophen

Begin treatment immediately at migraine onset with:

  • NSAIDs (aspirin, ibuprofen, naproxen, or diclofenac) as first-line therapy 1, 2
  • Acetaminophen as an alternative
  • Ensure patients use adequate dosing—many fail initial therapy simply because they're taking subtherapeutic doses 1

Critical pitfall: Before escalating therapy, verify the patient is actually taking the maximum recommended dose of their current medication. Consider increasing the NSAID or acetaminophen dose without exceeding daily limits if pain relief is inadequate 1.

Second-Line: Add a Triptan

If NSAIDs or acetaminophen alone fail at adequate doses, add a triptan to the NSAID (or to acetaminophen when NSAIDs cannot be used). 1 This combination approach is superior to either medication alone 2, 3.

Available triptans include: almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan, or zolmitriptan. Choose based on:

  • Route of administration preference (oral, nasal, subcutaneous)
  • Cost considerations
  • Individual patient response 1

Important: Patients who fail one triptan may respond to another within the same class—don't abandon triptans after a single agent fails 1.

Third-Line Options for Triptan Failures

For patients who don't tolerate or have inadequate response to triptan + NSAID combinations, consider 1:

  1. CGRP antagonists (gepants): rimegepant, ubrogepant, or zavegepant
  2. Dihydroergotamine (ergot alkaloid)
  3. Lasmiditan (5-HT1F agonist)—reserve as last-line option among pharmacologic treatments 1

Key advantage of gepants and lasmiditan: No vasoconstrictive effects, making them suitable for patients with cardiovascular risk factors who cannot use triptans 4, 5.

Special Considerations

Severe Nausea/Vomiting

Use nonoral triptan formulations plus antiemetics (domperidone or metoclopramide) 1, 2

Timing

Treat early—counsel patients to begin treatment as soon as the migraine starts, not after waiting to see if it worsens 1. Early treatment with combination therapy improves efficacy.

Route of Administration

Oral route is generally preferred by patients 1, but consider nasal spray or subcutaneous formulations for rapid onset or when oral absorption is compromised by nausea.

Medications to Absolutely Avoid

Do not use opioids or butalbital for acute migraine treatment 1, 2. These have questionable efficacy, substantial adverse effects, dependency risk, and no role in evidence-based migraine care.

Oral ergot alkaloids should also be avoided—they are poorly effective and potentially toxic 2.

Medication Overuse Headache Warning

Counsel patients about medication overuse headache, defined as headache on ≥15 days/month for ≥3 months due to overuse of acute medications 1. The threshold varies by medication type (≥15 days/month for NSAIDs/acetaminophen; ≥10 days/month for triptans, ergots, opioids, or combination analgesics) 3.

Pregnancy and Lactation

In patients of childbearing potential, pregnant, or breastfeeding individuals, discuss adverse effects of pharmacologic treatments and prioritize acetaminophen as the safest option for mild-to-moderate attacks 1, 3.

When to Consider Preventive Therapy

If episodic migraines occur frequently or acute treatment doesn't provide adequate response, adding preventive medications is warranted 1. This typically applies when patients remain adversely affected on ≥2 days per month despite optimized acute therapy 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.